The TORCH complex is a group of pathogens that can cause infections with mild or silent symptoms in an expecting mother, but ...
Study to evaluate the safety and exploratory efficacy of SYN002 in recipients of human cytomegalovirus (CMV) positive donor kidneys, and to monitor for viral reactivation over the six months following ...
Study to evaluate the safety and exploratory efficacy of SYN002 in recipients of human cytomegalovirus (CMV) positive donor kidneys, and to monitor for viral reactivation over the six months following ...
New Zealand's health authorities are proposing public funding for a breakthrough antiviral medicine aimed at protecting some of the country's most vulnerable patients following life-saving stem cell ...
Preclinical data demonstrate >90% reduction in human cytomegalovirus (HCMV) reactivation from latency, establishing proof-of-concept for SYN002 in human kidneys Data published in the American Journal ...
Maternal serology and interpretation of the results. Chatzakis et al. 12 in a meta-analysis, divided the fetal findings according to the period of maternal infection: periconceptional (4 weeks before ...
Federal data indicate that over half the US population aged 6-46 years is infected with cytomegalovirus (CMV), typically spread through bodily fluids. Most people have mild or no negative effects from ...
Company to discontinue development of mRNA-1647 in congenital CMV Company will continue to evaluate mRNA-1647 in ongoing ...
Cytomegalovirus (CMV) is a common pathogen, associated with mild illness in most immunocompetent people. Historically, research on CMV infection in the relatively immunocompromised premature and small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results